Defining the New Treatment Paradigm for Patients With Chronic Lymphocytic Leukemia

November 5, 2016

Learning Objectives

  • Recall all steps involved in the standard diagnostic workup and risk assessment for a CLL patient.
  • Discuss strategies for managing side effects of novel therapies, as well as preventing infections.
  • Describe best practices for optimizing selection and sequencing of treatments in the up-front and relapsed/refractory settings.
  • Apply updated practice guidelines on dosing and response monitoring.
Course summary
Available credit: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/05/2016
Course expires: 
04/30/2017
Event starts: 
11/05/2016 - 1:45pm
Event ends: 
11/05/2016 - 2:45pm
Cost:
$0.00
Rating: 
0
Gaylord National Hotel
National Harbor, MD
United States

Available Credit

  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.